title: Inactivated vaccines based on alternatives to wild-type seed virus.
authors.affiliation: Center for Biologics Evaluation and Research, FDA, Rockville, MD 20852, USA.
authors.forename: K
authors.initials: K
authors.lastname: Chumakov
authors.forename: E
authors.initials: E
authors.lastname: Dragunsky
authors.forename: A
authors.initials: A
authors.lastname: Ivshina
authors.forename: J
authors.initials: J
authors.lastname: Enterline
authors.forename: V
authors.initials: V
authors.lastname: Wells
authors.forename: T
authors.initials: T
authors.lastname: Nomura
authors.forename: M
authors.initials: M
authors.lastname: Gromeier
authors.forename: E
authors.initials: E
authors.lastname: Wimmer
mesh_terms: D000818:Animals; D000882:Haplorhini; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D011051:Poliomyelitis / Q000276:immunology / Q000517:prevention & control*; D017955:Poliovirus / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity; D011054:Poliovirus Vaccine, Inactivated / Q000276:immunology*; D011055:Poliovirus Vaccine, Oral / Q000276:immunology; D012229:Rhinovirus / Q000235:genetics / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D014774:Virulence
chemical_list: D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral; D014614:Vaccines, Synthetic